Assistant Clinical Professor of Dermatology, UC Irvine
Dermatology
Pamela Broska works in the field of Dermatology. She studied medicine at University of Connecticut School of Medicine. University of Connecticut School of Medicine is ranked 60 in research and 49 in primary care medicine She received 7 awards: "Palm Springs Life Magazine", "Top Doctors:LA Area", "Top Doctors:San Diego Area", "CMS Meaningful Use Stage 1 Certification", "Top Doctors:Southern California", "Fellow (FASDS)" and "Fellow (FAAD)". Doctor Pamela Broska, MD is a published doctor. She has 3 publications published. The most current publication "Vesicles and bulla in an infant. Bullous varicella (chicken pox complicated by bullous impetigo)." She is registered with Medicare and accepts Medicare payments.
Publications
Schools
University Of Connecticut School Of Medicine
St Mary Med Center
University Ca Irvine Med Center
Procedures Preformed
- Acne Surgery
- Adjacent Tissue Transfer
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- View All
Doctors Specialties
Accepted Insurances
Awards
- Palm Springs Life Magazine
- Top Doctors:LA Area
- Top Doctors:San Diego Area
- CMS Meaningful Use Stage 1 Certification
- Top Doctors:Southern California
- Fellow (FASDS)
- Fellow (FAAD)
Education
-
University of California Irvine
-
University of Connecticut School of Medicine
Drug Facts
NPI NUMBER |
|
1770535304 |
NPPES Provider LastName |
|
BROSKA |
NPPES Provider FirstName |
|
PAMELA |
NPPES Provider ZIPCode |
|
922703205 |
NPPES Provider State |
|
CA |
Specialty Description |
|
Dermatology |
Total Claim Count |
|
585.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1770535304 |
Last Name Of The Provider |
BROSKA |
First Name Of The Provider |
PAMELA |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog